Efficacy and Tolerability of intranasal fentanyl spray 50 to 200 µg for Breakthrough pain in patients with cancer: a phase II, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. - Kress,H.G.; Oronska,A.; Kaczmarek,Z. (Clin Ther, 2009)